Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lorraine Tulpin
Risk Factors for the Development of Brain Metastases in Patients With HER2-positive Breast Cancer
ESMO Open
Cancer Research
Oncology
Related publications
Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival
British Journal of Cancer
Cancer Research
Oncology
Development of a Risk Scoring System for Evaluating the Prognosis of Patients With Her2-Positive Breast Cancer
Cancer Cell International
Cancer Research
Oncology
Genetics
Risk Factors for Breast Cancer Brain Metastases: A Systematic Review
Oncotarget
Oncology
Risk Factors for Brain Metastases in Patients With Renal Cell Carcinoma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Radio-Sensitising Effect of T-Dm1 Should Not Be Discarded for the Efficacy of Radiosurgery in the Management of Brain Metastases in Patients With HER2-positive Metastatic Breast Cancer
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy
AboutOpen
Phase I Study of Intermittent High Dose Lapatinib Alternating With Capecitabine for HER2-positive Breast Cancer Patients With Central Nervous System Metastases
Clinical Cancer Research
Cancer Research
Oncology
Internodal HER2 Heterogeneity of Axillary Lymph Node Metastases in Breast Cancer Patients
Bosnian Journal of Basic Medical Sciences
Medicine
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
